Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification.
Saved in:
| Title: | Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification. |
|---|---|
| Authors: | Onakpoya IJ; Nuffield Department of Primary Care Health Sciences, Centre for Evidence-Based Medicine, University of Oxford, Gibson Building, Radcliffe Observatory Quarter, Oxford, OX2 6GG, UK. igho.onakpoya@kellogg.ox.ac.uk., Heneghan CJ; Nuffield Department of Primary Care Health Sciences, Centre for Evidence-Based Medicine, University of Oxford, Gibson Building, Radcliffe Observatory Quarter, Oxford, OX2 6GG, UK., Aronson JK; Nuffield Department of Primary Care Health Sciences, Centre for Evidence-Based Medicine, University of Oxford, Gibson Building, Radcliffe Observatory Quarter, Oxford, OX2 6GG, UK. |
| Source: | Drug safety [Drug Saf] 2017 May; Vol. 40 (5), pp. 431-441. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1942 |
|---|---|
| DOI: | 10.1007/s40264-017-0515-4 |
